Nanobody-enhanced chimeric antigen receptor T-cell therapy: overcoming barriers in solid tumors with VHH and VNAR-based constructs. [PDF]
Guo S, Xi X.
europepmc +1 more source
A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses. [PDF]
Feng B +15 more
europepmc +1 more source
Unusual traits shape the architecture of the Ig ancestor molecule. [PDF]
Urdiciain A +6 more
europepmc +1 more source
A Single-Domain VNAR Nanobody Binds with High-Affinity and Selectivity to the Heparin Pentasaccharide Fondaparinux. [PDF]
Gschwandtner M +11 more
europepmc +1 more source
Functional Divergence in the Affinity and Stability of Non-Canonical Cysteines and Non-Canonical Disulfide Bonds: Insights from a VHH and VNAR Study. [PDF]
Xu M +7 more
europepmc +1 more source
Isolation and Characterization of the First Antigen-Specific EGFRvIII vNAR from Freshwater Stingray (<i>Potamotrygon</i> spp.) as a Drug Carrier in Glioblastoma Cancer Cells. [PDF]
Manzanares-Guzmán A +7 more
europepmc +1 more source
Nanobodies: From Discovery to AI-Driven Design. [PDF]
Zhu H, Ding Y.
europepmc +1 more source
Marine Natural Products as Anticancer Agents 3.0. [PDF]
Alves C, Diederich M.
europepmc +1 more source
vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target. [PDF]
Manzanares-Guzmán A +2 more
europepmc +1 more source

